Search Results 441-450 of 17407 for bisphosphonates side effects

1. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

   The purpose of this study is to evaluate the side effects and best dose of nivolumab when given together with multi-fraction stereotactic radiosurgery and ...

2. Medical Research & Education - Mayo Clinic News Network

   ... side. Cancer. Joint study finds proton beam therapy helps patients with throat cancer live longer with fewer side effects. ROCHESTER, Minn. — Photon therapy ...

3. A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. ... Initiated low-dose corticosteroid, bisphosphonate, or denosumab therapy or adjusted low-dose corticosteroid, ...

4. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   About this study. This phase I/II trial studies the best dose and side effects of anetumab ravtansine when given together with atezolizumab and how well ...

5. Antidepressants and Bone Health - Mayo Clinic News Network

   ... adverse effects of anti-depressant drugs on bone.” The study included 3016 patients who had undergone pharmacogenetics testing between 2003 and 2013. Of ...

6. Or it could be due to various other treatable health conditions or medicine side effects. ... Some types of medicines cause dizziness as a side effect, including ...

7. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. ... Negative hepatitis B test (defined by a negative ... NOTE: Bisphosphonates are considered to be ...

8. TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery - Mayo Clinic

   This phase I trial studies the side effects and best dose of trifluridine/tipiracil hydrochloride combination agent TAS-102 (TAS-102) when given together ...

9. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

   This pilot phase I trial studies the side effects and best way to give sirolimus, gemcitabine hydrochloride, and cisplatin in treating patients at high risk ...

10. A Study of Tamoxifen Citrate for Treating Patients with Metastatic or Recurrent Breast Cancer - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... May not initiate bisphosphonate therapy while receiving treatment on this study.